Advertisement

Topics

Pfizer Upbeat After Bagging Besponsa Approval in US

08:34 EDT 18 Aug 2017 | SCRIP

It is the first CD22-directed antibody-drug conjugate indicated for relapsed or refractory B-cell precursor acute lymphoblastic leukemia, though sales potential...

      

Related Stories

 

Original Article: Pfizer Upbeat After Bagging Besponsa Approval in US

NEXT ARTICLE

More From BioPortfolio on "Pfizer Upbeat After Bagging Besponsa Approval in US"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...